Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Pang, Lu"'
Autor:
Xiao, Meng1, Pang, Lu1,2, Chen, Sharon C-A.3, Fan, Xin1, Zhang, Li1, Li, Hai-Xia2, Hou, Xin1, Cheng, Jing-Wei1, Kong, Fanrong3, Zhao, Yu-Pei4, Xu, Ying-Chun1 xycpumch@139.com
Publikováno v:
PLoS ONE. 1/25/2016, Vol. 11 Issue 1, p1-13. 13p.
Autor:
Nian-Kang Sun, Francene J.1,2, Hsin-Pang Lu, Francene J.1, Chao, Chuck C.-K.1 cckchao@mail.cgu.edu.tw
Publikováno v:
Journal of Biomedical Science. 2002, Vol. 9 Issue 4, p371-380. 10p. 8 Diagrams.
Publikováno v:
Cancer Science. 98:1206-1214
Our previous study identified a vincristine-selected multidrug resistance (MDR) cell line, HOB1/VCR, derived from a lymphoblastoma HOB1. The HOB1/VCR cells are resistant to typical MDR drugs and are cross-resistant to P-glycoprotein-independent drugs
Publikováno v:
Biochemical pharmacology. 93(1)
Prothymosin alpha (PTMA) is overexpressed in various human tumors, including hepatocellular carcinoma (HCC). The significance of PTMA overexpression and its underlying mechanism remain unclear. We show here that silencing PTMA sensitizes HCC cells to
Publikováno v:
Biochemical pharmacology. 82(2)
The hepatoma upregulated protein (HURP) represents a putative oncogene that is overexpressed in many human cancers, especially hepatocellular carcinoma (HCC). HURP plays an important role during mitotic spindle formation, a process that is targeted b
Publikováno v:
Biochemical pharmacology. 80(2)
The efficacy of cisplatin during cancer chemotherapy is often impaired by the emergence of cancer cells which become resistant to chemotherapeutic agents. While various mechanisms have been proposed to explain resistance to cisplatin, the genes invol